Exhibit 5.1
[Letterhead of Hogan Lovells US LLP]
July 25, 2019
Board of Directors
UnitedHealth Group Incorporated
UnitedHealth Group Center
9900 Bren Road East
Minnetonka, Minnesota 55343
Ladies and Gentlemen:
We are acting as counsel to UnitedHealth Group Incorporated, a Delaware corporation (the “Company”), in connection with the Underwriting Agreement, dated July 23, 2019 (the “Underwriting Agreement”), among the Company and BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., U.S. Bancorp Investments, Inc. and Wells Fargo Securities, LLC, as representatives (the “Representatives”) of the several underwriters named in the Pricing Agreement (as defined herein), and the Pricing Agreement, dated July 23, 2019 (the “Pricing Agreement”), among the Company and the Representatives relating to the proposed issuance by the Company of its (i) 2.375% Notes due August 15, 2024 in the aggregate principal amount of $750,000,000 (the “2024 Notes”), (ii) 2.875% Notes due August 15, 2029 in the aggregate principal amount of $1,000,000,000 (the “2029 Notes”), (iii) 3.500% Notes due August 15, 2039 in the aggregate principal amount of $1,250,000,000 (the “2039 Notes”), (iv) 3.700% Notes due August 15, 2049 in the aggregate principal amount of $1,250,000,000 (the “2049 Notes”) and (v) 3.875% Notes due August 15, 2059 in the aggregate principal amount of $1,250,000,000 (the “2059 Notes,” and collectively with the 2024 Notes, the 2029 Notes, the 2039 Notes and the 2049 Notes, the “Debt Securities”), pursuant to the Company’s automatic shelf registration statement on FormS-3(No. 333-216150) (the “Registration Statement”) filed with the Securities and Exchange Commission (the “Commission”) on February 21, 2017. This opinion letter is furnished to you at your request to enable you to fulfill the requirements of Item 601(b)(5) ofRegulation S-K, 17 C.F.R. § 229.601(b)(5), in connection with the Registration Statement.
For purposes of this opinion letter, we have examined copies of such agreements, instruments and documents as we have deemed an appropriate basis on which to render the opinions hereinafter expressed. In our examination of the aforesaid documents, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the accuracy and completeness of all documents submitted to us, the authenticity of all original documents, and the conformity to authentic original documents of all documents submitted to us as copies (including pdfs). As to all matters of fact, we have relied on the representations and statements of fact made in the documents so reviewed, and we have not independently established the facts so relied on. This opinion letter is given, and all statements herein are made, in the context of the foregoing.
For the purposes of this opinion letter, we have assumed that (i) U.S. Bank National Association, as trustee (the “Trustee”) under the Indenture, dated as of February 4, 2008, between the Company and the Trustee, filed as Exhibit 4.1 to the Registration Statement (the “Indenture”),